WHO IS AFT PHARMACEUTICALS

Learn about some of the people behind this dynamic Australasian company

The Board

David Flacks
David Flacks
Chairman
View More
Dr. Hartley Atkinson
Dr. Hartley Atkinson
View More
Marree Atkinson
Marree Atkinson
View More

David Flacks

Chairman

David is chair of the NZ Markets Disciplinary Tribunal and a member of the Takeovers Panel. Directorships include Vero Insurance, Asteron Liability, Harmoney Corp, and NZ Venture Investment Fund. David is a director of specialist corporate law firm Flacks & Wong, having recently retired from Bell Gully after many years as a senior corporate partner.

Close this window

Dr. Hartley Atkinson

Hartley has a Masters of Pharmaceutical Chemistry with Distinction (1983) and Doctorate in Pharmacology from Otago University (1989). He published 17 research papers and 2 book chapters prior to entering industry. Before establishing AFT Pharmaceuticals, Hartley had 8 years in multinational pharmaceutical companies in various positions including Medical Director and Sales and Marketing Director.

Close this window

Marree Atkinson

Prior to co-founding AFT Pharmaceuticals, Marree was a registered nurse at Waikato Hospital. She also worked with Air New Zealand. Marree has been a central figure in building the company since its inception. She has directed developments across key parts of the business, including financial control, regulatory/compliance, brand awareness, international market growth and human resources. She is the company’s Chief of Staff overseeing staff, commercial contracts, and special projects.

Close this window
Doug Wilson
Doug Wilson
View More
Jon Lamb
Jon Lamb
View More
Nathan Hukill
Nathan Hukill
View More

Doug Wilson

Doug Wilson was a New Zealand physician and academic. He joined a major International pharmaceutical company, Boehringer Ingelheim, working in their US subsidiary, becoming their Head of Medical Research and Regulatory Affairs, the interface with FDA, playing a major role in steering 10 drugs through the FDA to the US and global markets. He moved to Head Office in Germany, being responsible for those same functions for worldwide drug development. He chaired the company’s International Medical Committee overseeing the medical aspects of all drugs in development globally, and their Internal Labeling Committee for the drugs on the worldwide market. He was the medical parent of Spiriva, a drug for Chronic Obstructive Pulmonary Disease (COPD) one of the major global killers. The drug last year sold $5 billion. He now consults internationally on new drugs in development, and for pharmaceutical companies.

Close this window

Jon Lamb

Jon has lead strategic planning, marketing and restructuring of companies throughout his career. He worked in and headed a multinational pharmaceutical company successfully launching global brands. He created the kiwifruit brand Zespri, and restructured the company into a retail focused operation. He has been a board director on a number of public and private companies, for example a recent a start-up that was developing an antiviral against AIDS where he worked closely with Harvard Medical School who sponsored the clinical trials. He was Deputy Chair of an Australian diagnostic company that had a real time tool for measuring the Hepatitis B virus. He has been involved with AFT Pharmaceuticals Ltd since 2004. He is a member of the Institute of Directors.

Close this window

Nathan Hukill

Nate Hukill is the President and Chairman of CRG’s investment committee and opened the firm’s Boulder office. Mr. Hukill joined CRG in 2009, bringing more than 16 years of investing experience. Prior to joining CRG, Mr. Hukill was a Portfolio Manager at Highland Capital, where he invested and managed approximately $4.5 billion in the healthcare, consumer products, and technology sectors. Before Highland Capital, Mr. Hukill co-founded a pharmaceutical-focused enterprise software company called OpenQ, Inc. He started his career as a credit investor at Salomon Smith Barney where he managed a portfolio of approximately $800 million.

Close this window
Jim Burns
Jim Burns
View More

Jim Burns

Jim is Chairman of Assurex Health, and from 2009-2015 served as Executive Chairman and Chief Executive Officer. Previous roles include President of MedPointe Pharmaceuticals, President & CEO of Osiris Therapeutics, General Partner of Healthcare Ventures and Group President of Becton Dickinson.

Close this window

Management

Dr. Hartley  Atkinson
Dr. Hartley Atkinson
Managing Director
View More
Malcolm  Tubby
Malcolm Tubby
Chief Financial Officer
View More
Ioana Stanescu
Ioana Stanescu
Head of Drug Development
View More

Dr. Hartley Atkinson

Managing Director

Hartley has a Masters of Pharmaceutical Chemistry with Distinction (1983) and Doctorate in Pharmacology from Otago University (1989). He published 17 research papers and 2 book chapters prior to entering industry. Before establishing AFT Pharmaceuticals, Hartley had 8 years in multinational pharmaceutical companies in various positions including Medical Director and Sales and Marketing Director.

Close this window

Malcolm Tubby

Chief Financial Officer

Malcolm is a qualified Chartered Accountant in the United Kingdom and New Zealand with a wealth of senior corporate governance expertise in the commerce sector including roles in significant public companies as Chief Financial Officer. He has experience in senior positions in public and private companies in pharmaceuticals, beverages, insurance and aged care facilities in Australia and New Zealand. Malcolm has been involved in the AFT board since its foundation. Malcolm is also the CFO for AFT Pharmaceuticals.

Close this window

Ioana Stanescu

Head of Drug Development

Ioana has overall responsibility for the research & development functions of the company. She has more than 20 years experience in the pharmaceutical industry with previous positions, including VP QA & Regulatory Affairs, Head of Vaccine Business Area at FIT Biotech Ltd, and a World Health Organisation adviser performing institutional assessments of National Regulatory Authorities within Central and Eastern Europe. She has coordinated a variety of European FP6 and FP7 funded research grants. In 1999 she was selected as an Expert by the European Health Committee - Council of Europe to participate in the coordinated research study of viral inactivation of labile blood products. She is also a Member of the European QP Association.

Close this window
Vladimir Ilievski
Vladimir Ilievski
Regulatory Affairs Manager
View More

Vladimir Ilievski

Regulatory Affairs Manager

Vladimir was born and raised in Macedonia. He holds a Masters degree in Pharmacy from the University of Ljubljana, Slovenia, where he started his career as a pre-clinical researcher before moving to New Zealand. Prior to joining AFT Pharmaceuticlas, Vladimir worked for Douglas Pharmaceuticals in various roles including as QC and QA analyst and regulatory/senior regulatory associate. He joined AFT Pharmaceuticals in 2006 as Regulatory Affairs Manager. Vladimir has responsibility for product registrations in various countries such as New Zealand, Australia, South-East Asia (Malaysia, Singapore, Hong Kong,Philippines) as well as the European Union and USA.

Close this window

R&D Team

Charles Beasley (MBE)
Charles Beasley (MBE)
Research & Development Project Manager
View More
Irenee J P Stewart (Dip.N BN & HlthSc)
Irenee J P Stewart (Dip.N BN & HlthSc)
Senior Clinical Research Associate
View More
Jennifer Zhang (MD)
Jennifer Zhang (MD)
Senior Clinical Research Associate, Drug Safety Officer
View More

Charles Beasley (MBE)

Research & Development Project Manager

Charles joined the R&D team at AFT Pharmaceuticals after completing a Masters Degree in Bioscience Enterprise in 2014. His university career covered a variety of different disciplines from structural and microbiology to venture capital to pharmacoeconomics. He also comes from a very musical family and background and has played as a session musician (drummer) for a number of years.    

Close this window

Irenee J P Stewart (Dip.N BN & HlthSc)

Senior Clinical Research Associate

Prior to joining AFT, Irenee worked as a healthcare professional within the public and private sectors, including management. She has a long-standing interest in science, as well as gathering factual information and documentation. She has been with AFT for three years in her current role of Clinical Research Associate. The role is very diverse, and allows her to work collaboratively across the R&D team.

Close this window

Jennifer Zhang (MD)

Senior Clinical Research Associate, Drug Safety Officer

 Jennifer previously worked at Wyeth Asia Pacific R&D Centre as Senior CRA, overviewing a variety of FDA compliant studies.  She joined AFT Pharmaceuticals Ltd almost nine years ago and holds the position of Senior Clinical Research Associate and Drug Safety Officer, assisting in all the clinical development programs and being the main responsible person for the pharmaco vigilance activities in the company.

 

Close this window